Trials / Completed
CompletedNCT01623622
Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke
A Phase 2 Study of HC-58 in Patients With Severe Upper Limb Hemiplegia After Stroke
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 270 (estimated)
- Sponsor
- Asahi Kasei Therapeutics Corporation · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the efficacy and safety of HC-58 in patients with severe upper limb hemiplegia following stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HC-58 | once or more / week |
| DRUG | Placebo | once or more / week |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
- First posted
- 2012-06-20
- Last updated
- 2017-02-15
Locations
3 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01623622. Inclusion in this directory is not an endorsement.